Trial · NCT03559530
Acinetobacter Baumannii-related Osteomyelitis: Clinical and Epidemiological Characterization
NCT03559530, Completed, University of Sao Paulo; results first posted 2021-05-18
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Acinetobacter Baumannii-related Osteomyelitis: Clinical and Epidemiological Characterization. Trials, record NCT03559530. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT03559530
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Acinetobacter Baumannii-related Osteomyelitis: Clinical and Epidemiological Characterization
- NCT number
- NCT03559530
- Status
- Completed
- Enrollment
- 262 participants, actual
- Lead sponsor
- University of Sao Paulo
- Conditions
- Osteomyelitis
- Interventions
- Antimicrobial
- First posted
- 2018-06-18
- Last updated
- 2021-05-18
- Results first posted
- 2021-05-18
Source ClinicalTrials.gov
Registered outcomes2
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Description of the Clinical and Epidemiological Profile of Patients With Infection | 6 months | Distribution of the clinical and epidemiological characteristics studied among the patients. Use of percentage and average for description. |
| Secondary | A. Baumannii Susceptibility Profile | 6 months | A. baumannii isolates susceptible to the tested antimicrobials |
Source ClinicalTrials.gov
Outcomes2
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
| Type | Outcome | Time frame | Population | Units | Measured as |
|---|---|---|---|---|---|
| PRIMARY | Description of the Clinical and Epidemiological Profile of Patients With Infection | 6 months | Described above. | Participants | COUNT_OF_PARTICIPANTS |
| SECONDARY | A. Baumannii Susceptibility Profile | 6 months | Percentage of patients with carbapenem-susceptible isolates of A. baumannii | Participants | COUNT_OF_PARTICIPANTS |
Source ClinicalTrials.gov
Results by group7
Each measurement the trial posted, group by group, in the words and numbers it posted.
| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Description of the Clinical and Epidemiological Profile of Patients With Infection | Patients | Remission | 92 | Participants | |
| Description of the Clinical and Epidemiological Profile of Patients With Infection | Patients | Relapse | 26 | Participants | |
| Description of the Clinical and Epidemiological Profile of Patients With Infection | Patients | Amputation | 25 | Participants | |
| Description of the Clinical and Epidemiological Profile of Patients With Infection | Patients | Lost follow-up | 21 | Participants | |
| Description of the Clinical and Epidemiological Profile of Patients With Infection | Patients | Death related to A. baumannii infection | 6 | Participants | |
| Description of the Clinical and Epidemiological Profile of Patients With Infection | Patients | Death not related to A. baumannii infection | 1 | Participants | |
| A. Baumannii Susceptibility Profile | Susceptibility Profile of A. Baumannii Isolates Over Time | 57 | Participants |
Source ClinicalTrials.gov
Participant flow6
How many started, completed or left each group, period by period.
| Period | Milestone | Group | Participants | Units counted |
|---|---|---|---|---|
| Overall Study | STARTED | Carbapenem Susceptible A. Baumannii | 197 | |
| Overall Study | STARTED | XDR Acinetobacter Baumannii | 65 | |
| Overall Study | COMPLETED | Carbapenem Susceptible A. Baumannii | 106 | |
| Overall Study | COMPLETED | XDR Acinetobacter Baumannii | 65 | |
| Overall Study | NOT COMPLETED | Carbapenem Susceptible A. Baumannii | 91 | |
| Overall Study | NOT COMPLETED | XDR Acinetobacter Baumannii | 0 |
Source ClinicalTrials.gov
Adverse events5
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| serious | Renal impairment | General disorders | XDR A. Baumannii | 27 | 65 | 27 |
| serious | Liver abnormalities | Hepatobiliary disorders | XDR A. Baumannii | 2 | 65 | 2 |
| serious | Nausea | Gastrointestinal disorders | XDR A. Baumannii | 4 | 65 | 4 |
| serious | Skin rash | Immune system disorders | XDR A. Baumannii | 1 | 65 | 1 |
| serious | Other | Investigations | XDR A. Baumannii | 7 | 65 | 7 |
Source ClinicalTrials.gov
Adverse event totals3
The totals the trial posted for each group.
| Total | Group | Affected | At risk |
|---|---|---|---|
| Total, all-cause mortality | XDR A. Baumannii | 7 | 65 |
| Total, other adverse events | XDR A. Baumannii | 0 | 65 |
| Total, serious adverse events | XDR A. Baumannii | 36 | 65 |
Source ClinicalTrials.gov
Papers0
The papers the trial lists on ClinicalTrials.gov.
None in this release.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT03559530
GET https://conductscience.org/api/trials/v1/NCT03559530/registered